Cargando…

Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine

PURPOSE: To report a case of a healthy, young male with recurrent herpes zoster ophthalmicus (HZO) and high-dose l-arginine supplementation. OBSERVATIONS: A 39-year-old man presented to another institution with a HZO involving the right eye. He was treated with oral acyclovir with complete resolutio...

Descripción completa

Detalles Bibliográficos
Autores principales: LoBue, Stephen A., Tailor, Prashant, Carlson, Stacy M., Mano, Fukutaro, Giovane, Richard A., Schaefer, Erin, LoBue, Thomas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722283/
https://www.ncbi.nlm.nih.gov/pubmed/31497676
http://dx.doi.org/10.1016/j.ajoc.2019.100547
_version_ 1783448502890659840
author LoBue, Stephen A.
Tailor, Prashant
Carlson, Stacy M.
Mano, Fukutaro
Giovane, Richard A.
Schaefer, Erin
LoBue, Thomas D.
author_facet LoBue, Stephen A.
Tailor, Prashant
Carlson, Stacy M.
Mano, Fukutaro
Giovane, Richard A.
Schaefer, Erin
LoBue, Thomas D.
author_sort LoBue, Stephen A.
collection PubMed
description PURPOSE: To report a case of a healthy, young male with recurrent herpes zoster ophthalmicus (HZO) and high-dose l-arginine supplementation. OBSERVATIONS: A 39-year-old man presented to another institution with a HZO involving the right eye. He was treated with oral acyclovir with complete resolution. Four months later the patient had a recurrent HZO episode and was started again on oral acyclovir. After resolution of the episode, the patient was continued on 1 g of oral acyclovir daily as a prophylactic measure. He then presented to our institution for a second opinion. The patient was otherwise healthy, with no past medical history involving systemic immunosuppressant agents or HIV. However, the patient was an active weight lifter taking high doses of amino acids. A diet recall was performed prior to both HZO episodes, which calculated an average intake of 46.5 g of l-arginine a day. Examination revealed 20/40 best-corrected acuity, anterior stromal haze in the visual axis, and inferior superficial punctate keratitis in the right eye. The patient was treated for dry eye disease with punctual plugs and artificial tears. The patient was instructed to decrease all supplemental arginine consumption while continuing with oral acyclovir prophylaxis for one year. CONCLUSIONS AND IMPORTANCE: l-arginine is associated with the replication and virulence of a variety of viruses in vitro, including herpes simplex and varicella zoster. Although arginine consumption increased prior to the initial and recurrent HZO infection, further investigation needs to be performed to deem if a true association exists.
format Online
Article
Text
id pubmed-6722283
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67222832019-09-06 Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine LoBue, Stephen A. Tailor, Prashant Carlson, Stacy M. Mano, Fukutaro Giovane, Richard A. Schaefer, Erin LoBue, Thomas D. Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of a healthy, young male with recurrent herpes zoster ophthalmicus (HZO) and high-dose l-arginine supplementation. OBSERVATIONS: A 39-year-old man presented to another institution with a HZO involving the right eye. He was treated with oral acyclovir with complete resolution. Four months later the patient had a recurrent HZO episode and was started again on oral acyclovir. After resolution of the episode, the patient was continued on 1 g of oral acyclovir daily as a prophylactic measure. He then presented to our institution for a second opinion. The patient was otherwise healthy, with no past medical history involving systemic immunosuppressant agents or HIV. However, the patient was an active weight lifter taking high doses of amino acids. A diet recall was performed prior to both HZO episodes, which calculated an average intake of 46.5 g of l-arginine a day. Examination revealed 20/40 best-corrected acuity, anterior stromal haze in the visual axis, and inferior superficial punctate keratitis in the right eye. The patient was treated for dry eye disease with punctual plugs and artificial tears. The patient was instructed to decrease all supplemental arginine consumption while continuing with oral acyclovir prophylaxis for one year. CONCLUSIONS AND IMPORTANCE: l-arginine is associated with the replication and virulence of a variety of viruses in vitro, including herpes simplex and varicella zoster. Although arginine consumption increased prior to the initial and recurrent HZO infection, further investigation needs to be performed to deem if a true association exists. Elsevier 2019-08-20 /pmc/articles/PMC6722283/ /pubmed/31497676 http://dx.doi.org/10.1016/j.ajoc.2019.100547 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
LoBue, Stephen A.
Tailor, Prashant
Carlson, Stacy M.
Mano, Fukutaro
Giovane, Richard A.
Schaefer, Erin
LoBue, Thomas D.
Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
title Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
title_full Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
title_fullStr Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
title_full_unstemmed Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
title_short Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
title_sort recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-arginine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722283/
https://www.ncbi.nlm.nih.gov/pubmed/31497676
http://dx.doi.org/10.1016/j.ajoc.2019.100547
work_keys_str_mv AT lobuestephena recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine
AT tailorprashant recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine
AT carlsonstacym recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine
AT manofukutaro recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine
AT giovanericharda recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine
AT schaefererin recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine
AT lobuethomasd recurrentherpeszosterophthalmicusinayounghealthyindividualtakinghighdosesoflarginine